LP
SYRS

LMR Partners’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

LMR Partners’s Portfolio SYRS Stock Details SYRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2,738
Closed -$26K – 1313
2022
Q2 		$26K Buy
+2,738
New +$26K ﹤0.01% 1212